{
    "2020-12-09": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Novartis Kisqali速 data demonstrate superior benefit across main intrinsic subtypes in metastatic breast cancer",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Kisqali速",
                        "superior benefit",
                        "intrinsic subtypes",
                        "metastatic breast cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Novartis Kisqali速 demonstrates nearly five years median overall survival in metastatic breast cancer",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Kisqali速",
                        "five years",
                        "median overall survival",
                        "metastatic breast cancer"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}